Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
NCT00911729 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2013-06-10
Summary
The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.
Conditions
- Pheochromocytoma
- Paraganglioma
Sponsors & Collaborators
-
Molecular Insight Pharmaceuticals, Inc.
lead INDUSTRY
Principal Investigators
-
Emuella M Flood, BS · Oxford Outcomes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
Countries
- United States
Study Locations
More Related Trials
-
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 ·Status: RECRUITING
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
NCT04087902 ·Status: ACTIVE_NOT_RECRUITING
-
Brain Tumor Treatment Satisfaction Survey
NCT00557375 ·Status: COMPLETED
-
Craniopharyngioma and Pregnancies
NCT06801756 ·Status: RECRUITING
-
Validation of a Quality of Life Metric "Prolac-10"
NCT04106531 ·Status: TERMINATED
-
Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
NCT02396810 ·Status: TERMINATED ·Phase: NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
NCT02544022 ·Status: RECRUITING
-
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
NCT05158712 ·Status: UNKNOWN
-
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
NCT01556230 ·Status: COMPLETED
-
Characterization of Receptors in Non-functioning Pituitary Macroadenomas
NCT00852501 ·Status: UNKNOWN
-
Quality of Life and Patient Needs in Advanced High Grade Gliomas
NCT05039346 ·Status: COMPLETED
-
Endocrine Outcome of Surgery for Pituitary Adenoma
NCT03515603 ·Status: TERMINATED ·Phase: NA
-
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
NCT02160925 ·Status: COMPLETED ·Phase: NA
-
Neuromodulation for Hypothalamic Obesity
NCT03708913 ·Status: WITHDRAWN ·Phase: NA
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
NCT05124964 ·Status: RECRUITING
-
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT06059690 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
NCT07226453 ·Status: RECRUITING ·Phase: PHASE2
-
Food Preferences and Craniopharyngiomas
NCT07301554 ·Status: NOT_YET_RECRUITING
-
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
NCT01106794 ·Status: RECRUITING
-
Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions
NCT06705036 ·Status: RECRUITING
-
Hereditary Pheochromocytoma Assessment of Tumour Immunologies
NCT06444607 ·Status: RECRUITING
-
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
NCT02792582 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
NCT05238909 ·Status: ENROLLING_BY_INVITATION
-
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
NCT04004377 ·Status: UNKNOWN